miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition.

miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition.
复制标题

miR-29b通过下调TIAM1表达并抑制上皮 - 间质转变,从而抑制结直肠癌的肿瘤生长和转移。

DOI:
10.1038/cddis.2014.304
复制
发表时间:
2014-07-17
影响因子:
9
通讯作者:
Zhao, L.
Zhao, L.
中科院分区:
生物学1区
文献类型:
--
作者:
Wang, B.;Li, W.;Liu, H.;Yang, L.;Liao, Q.;Cui, S.;Wang, H.;Zhao, L.

文献摘要

参考文献

被引文献

相似文献

最近,miR-29 b在结直肠癌(CRC)发展中的作用似乎存在争议。miR-29 b在结直肠癌中的表达及功能尚不清楚。我们发现miR-29 b的表达降低通常发生在CRC细胞系和组织样本中。体外功能丧失和获得测定揭示了miR-29 b对细胞增殖和迁移的抑制作用。内源性miR-29 b过表达足以抑制小鼠的攻击性行为表型。蛋白质组学分析表明,miR-29 b参与了多种关键的生物学过程。此外,miR-29 b还介导了上皮-间质转化(EMT)的抑制以及丝裂原活化蛋白激酶和磷脂酰肌醇-4,5-二磷酸3-激酶/AKT信号转导通路的失活。进一步的研究发现T淋巴瘤侵袭和转移1(Tiam 1)被确定为miR-29 b的直接靶点。与miR-29 b修复诱导的表型相反,Tiam 1诱导的细胞增殖和迁移部分挽救了miR-29 b介导的生物学行为。我们的研究结果表明,miR-29 b作为一种抑制剂在CRC进展中起着关键作用,这表明其在晚期CRC患者的分子治疗中具有潜在的作用。
Recently, the role of miR-29b in colorectal carcinoma (CRC) development appears to be controversial. Until now, the expression and function of miR-29b in CRC have not been clarified clearly. We showed that decreased expression of miR-29b usually occurred in CRC cell lines and tissue samples. Loss- and gain-of-function assays in vitro revealed suppressive effects of miR-29b on cell proliferation and migration. Endogenous overexpression of miR-29b was sufficient to suppress aggressive behavioral phenotypes in mice. Proteomic analysis showed that miR-29b involved in integrate several key biological processes. In addition, miR-29b mediated the inhibition of epithelial–mesenchymal transition (EMT) and the inactivation of mitogen-activated protein kinase and phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT signal transduction pathway. Further studies found that T lymphoma invasion and metastasis 1 (Tiam1) was identified as a direct target of miR-29b. In contrast to the phenotypes induced by miR-29b restoration, Tiam1-induced cell proliferation and migration partly rescued miR-29b-mediated biological behaviors. Our results illustrated that miR-29b as a suppressor has a critical role in CRC progression, which suggests its potential role in the molecular therapy of patients with advanced CRC.
DOI: 10.1038/sj.onc.1206817
发表时间: 2003-10-16
期刊: ONCOGENE
影响因子: 8
作者:
Uematsu, K;He, BA;Jablons, DM
通讯作者: Jablons, DM
DOI: 10.1089/dna.2006.0566
发表时间: 2007-04-01
影响因子: 3.1
作者:
Ioshikhes, Ilya;Roy, Sashwati;Sen, Chandan K.
通讯作者: Sen, Chandan K.
DOI: 10.1158/1535-7163.mct-12-0100
发表时间: 2012-05-01
影响因子: 5.7
作者:
Ru, Peng;Steele, Robert;Ray, Ratna B.
通讯作者: Ray, Ratna B.
DOI: 10.1111/igc.0b013e3181a48cf9
发表时间: 2009-05-01
影响因子: 4.8
作者:
Flavin, Richard;Smyth, Paul;O'Leary, John J.
通讯作者: O'Leary, John J.
DOI: 10.1038/aps.2013.134
发表时间: 2013-11
影响因子: 8.2
作者:
Wang, Zheng-ming;Du, Wen-jun;Piazza, Gary A.;Xi, Yaguang
通讯作者: Xi, Yaguang